|
|
Volumn 301, Issue 16, 2009, Pages 1643-1645
|
|
Findings on alcohol dependence point to promising avenues for targeted therapies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACAMPROSATE;
ANTINEOPLASTIC AGENT;
BACLOFEN;
DISULFIRAM;
LY 686017;
NALTREXONE;
TACHYKININ RECEPTOR ANTAGONIST;
UNCLASSIFIED DRUG;
VARENICLINE;
BENZAZEPINE DERIVATIVE;
CORTICOTROPIN RELEASING FACTOR RECEPTOR;
CRF RECEPTOR TYPE 1;
LY686017;
MU OPIATE RECEPTOR;
NARCOTIC ANTAGONIST;
NEUROKININ 1 RECEPTOR;
NICOTINIC AGENT;
OPRM1 PROTEIN, HUMAN;
PYRIDINE DERIVATIVE;
QUINOXALINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ALCOHOL CONSUMPTION;
ALCOHOLISM;
CLINICAL TRIAL;
DRINKING BEHAVIOR;
GENETIC ANALYSIS;
HUMAN;
NAUSEA;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SMOKING CESSATION;
ANIMAL;
DRUG ANTAGONISM;
GENETICS;
MENTAL STRESS;
METABOLISM;
NOTE;
PHARMACOGENETICS;
ALCOHOLISM;
ANIMALS;
BENZAZEPINES;
HUMANS;
NALTREXONE;
NARCOTIC ANTAGONISTS;
NICOTINIC AGONISTS;
PHARMACOGENETICS;
PYRIDINES;
QUINOXALINES;
RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;
RECEPTORS, NEUROKININ-1;
RECEPTORS, OPIOID, MU;
STRESS, PSYCHOLOGICAL;
TRIAZOLES;
|
|
EID: 65249155886
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.535 Document Type: Short Survey |
|
Times cited : (15)
|
|
References (0)
|